Camrelizumab as adjuvant therapy in urothelial carcinomas after radical surgery in people living with HIV.
International journal of STD & AIDS（2023）
摘要
Camrelizumab showed potent antitumor activity and acceptable safety in PLWH with advanced or metastatic urothelial carcinoma.
更多查看译文
关键词
urothelial carcinoma, HIV, camrelizumab, adjuvant therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要